Skip to main content

Patient guide · Urology

Rigid cystoscopy, theatre-based bladder examination — usually combined with biopsy or TURBT.

Rigid cystoscopy is a theatre-based bladder examination under general or spinal anaesthesia — nearly always combined with biopsy or transurethral resection of bladder tumour (TURBT). The definitive investigation and initial treatment for bladder cancer.

Read the key facts
A private rigid cystoscopy theatre in a London concierge clinic

Why patients choose us

  • 01

    The right hands

    We route you to a consultant urologist who performs high volumes of rigid cystoscopy and TURBT — the person operating decides the answer.

  • 02

    Day-case, not overnight

    Rigid cystoscopy with biopsy or TURBT is a day-case in our network — in for the morning, home the same evening in most cases.

  • 03

    Independent, and free

    We are paid by no clinic, so the recommendation is impartial and costs you nothing.

Key facts

What rigid cystoscopy is, in six lines.

The essentials — what the procedure is, when it’s done, and why it matters for bladder cancer diagnosis and treatment.

  • Definition

    Theatre-based rigid bladder examination performed under general or spinal anaesthesia.

  • Usually combined

    Nearly always combined with bladder biopsy or transurethral resection of bladder tumour (TURBT).

  • Day-case procedure

    Admitted, treated and discharged the same day in the majority of patients.

  • Higher-quality inspection

    Larger channels, better optics and irrigation give a superior view compared with flexible cystoscopy.

  • Enables removal + histology

    Allows resection of suspicious lesions with muscle in the specimen — essential for accurate staging.

  • Standard pathway

    The standard bladder-cancer diagnostic and initial treatment procedure worldwide.

Preparation

From consent to catheter — what happens, in order.

Same consultant urologist from consultation to discharge — usually a single day-case admission.

  1. 01

    Before

    Urology consultation and consent

    A consultant urologist reviews imaging and flexible cystoscopy findings, explains the plan and takes formal consent.

  2. 02

    Before

    Pre-operative assessment

    Bloods, ECG, MRSA screen and anaesthetic review — usually completed in a single pre-op clinic visit.

  3. 03

    Before

    Fast 6 hours pre-procedure

    Nothing to eat for 6 hours before theatre. Clear fluids permitted up to 2 hours before.

  4. 04

    On the day

    General or spinal anaesthesia

    Anaesthetic given in the anaesthetic room. Spinal is an option if general anaesthesia is contraindicated.

  5. 05

    On the day

    Rigid scope inserted

    Rigid cystoscope passed via the urethra — the whole bladder mucosa is systematically inspected.

  6. 06

    On the day

    Suspicious lesions resected (TURBT)

    Any tumour is resected with a diathermy loop, taking muscle in the specimen for staging.

  7. 07

    After

    Post-op catheter and bladder washout

    A catheter drains the bladder overnight or for a few hours, with continuous washout if bleeding is present.

Typical admission: day-case. Overnight stay: only if clinically indicated.

What it shows

What rigid cystoscopy answers.

Rigid cystoscopy with TURBT is the definitive way to diagnose, stage and initially treat bladder cancer. These are the findings that shape the plan.

  • Non-muscle-invasive bladder cancer (Ta / T1 / CIS)

    The commonest finding — superficial tumour confined to mucosa or lamina propria, treated by resection.

  • Muscle-invasive bladder cancer (T2+)

    Deeper invasion identified histologically — triggers staging CT and MDT discussion of radical treatment.

  • Tumour multifocality and location

    Maps every lesion in the bladder — critical for planning surveillance and intravesical therapy.

  • Depth of resection

    Muscle in the TURBT specimen confirms adequate resection depth for accurate T-staging.

  • Bladder stones

    Stones can be visualised and fragmented at the same sitting if identified.

  • Prostatic urethra assessment

    The prostatic urethra is inspected for tumour extension in high-risk cases.

  • Intravesical mitomycin post-TURBT

    A single dose of intravesical chemotherapy is instilled at the end of the procedure to reduce recurrence.

  • Red flag: bladder perforation intra-op — urgent surgical repair

    Rare but serious. Recognised intra-operatively and managed by catheter drainage or open repair.

Next steps

What follows a positive TURBT.

Risk-stratified by histology and imaging — from a single dose of mitomycin at the end of the case, through BCG, to radical cystectomy.

  • Single-dose post-TURBT mitomycin

    Intravesical chemotherapy at the end of the procedure — reduces recurrence in low- and intermediate-risk NMIBC.

  • Repeat TURBT for high-risk T1

    A second TURBT within 6 weeks for high-grade or incompletely resected T1 disease — confirms staging and completes resection.

  • Intravesical BCG for high-risk NMIBC

    Weekly BCG instillations for induction, then maintenance — the standard adjuvant for high-risk non-muscle-invasive disease.

  • Radical cystectomy for MIBC

    Removal of the bladder with urinary diversion — the gold standard for muscle-invasive bladder cancer.

  • Neoadjuvant chemotherapy

    Cisplatin-based chemotherapy before cystectomy improves survival in fit patients with MIBC.

  • Bladder-preserving chemoradiotherapy

    An alternative to cystectomy for selected patients — combined chemotherapy and radiotherapy with cystoscopic surveillance.

  • Surveillance cystoscopy schedule

    Risk-stratified follow-up cystoscopies — typically at 3 months, then at intervals depending on risk group.

  • MDT review

    Every new bladder cancer is discussed at a urology MDT to agree the plan across urology, oncology and pathology.

Red flags

When to call the ward, not wait.

Rigid cystoscopy is very safe, but a small set of complications need urgent attention — intra-operatively or after discharge.

  • Bladder perforation intra-op

    Rare but serious. Recognised in theatre and managed by prolonged catheterisation or open surgical repair.

  • Post-op urosepsis

    Fever, rigors and confusion after discharge — needs urgent IV antibiotics and hospital assessment.

  • Failed anaesthetic

    Reactions to general or spinal anaesthesia — uncommon but require immediate anaesthetic input.

  • Post-TURBT bleeding

    Heavy haematuria or clot retention after discharge — return to hospital for washout.

  • Chemical cystitis post-mitomycin

    Bladder irritation from intravesical chemotherapy — usually self-limiting but occasionally severe.

  • High-grade tumour

    Aggressive histology on the TURBT specimen — needs urgent MDT review and consideration of repeat TURBT or BCG.

  • Muscle-invasive disease

    T2 disease or worse changes the pathway entirely — staging CT, MDT and radical treatment planning.

  • Concurrent upper-tract urothelial carcinoma

    Bladder cancer can coexist with upper-tract disease — CT urogram is essential in high-risk patients.

  • Post-BCG intolerance

    Some patients cannot tolerate intravesical BCG — alternative intravesical or early cystectomy is then considered.

Sources

The guidance this page follows.

Written from primary UK and international urology guidance. Reviewed Pulse Atlas Editorial Board, . Next review 2027-07-30.

A quiet reminder

This page informs — it does not replace your consultant urologist.

Read it, then take your questions into your consultation.

  1. 01 Reference

    NICE. Bladder cancer: diagnosis and management (NG2).

    NICE. Bladder cancer: diagnosis and management (NG2).
  2. 02 Reference

    European Association of Urology. Guidelines on bladder cancer.

    European Association of Urology. Guidelines on bladder cancer.
  3. 03 Reference

    British Association of Urological Surgeons. Bladder cancer resources.

    British Association of Urological Surgeons. Bladder cancer resources.
  4. 04 Reference

    American Urological Association. Bladder cancer guidelines.

    American Urological Association. Bladder cancer guidelines.

Recognised by major UK insurers

BupaAXA HealthVitalityAvivaWPACignaHealixBupaAXA HealthVitalityAvivaWPACignaHealixBupaAXA HealthVitalityAvivaWPACignaHealix

Cover depends on your policy and clinic; we confirm with your insurer before booking.

Frequently asked

Everything patients ask about rigid cystoscopy.

Quick answers on the difference from flexible cystoscopy, TURBT, day-case discharge, and what to do if the biopsy shows cancer.

  • What is a rigid cystoscopy?

    A theatre-based examination of the bladder using a rigid metal cystoscope, performed under general or spinal anaesthesia. It is nearly always combined with bladder biopsy or transurethral resection of bladder tumour (TURBT).

  • How is rigid cystoscopy different from flexible cystoscopy?

    Flexible cystoscopy is an outpatient look-see under local anaesthetic — it diagnoses but rarely treats. Rigid cystoscopy is a theatre procedure under anaesthesia, giving a superior view and — crucially — allowing biopsy and tumour resection at the same sitting.

  • What is TURBT?

    Transurethral resection of bladder tumour — the removal of bladder cancer via the rigid cystoscope using a diathermy loop. TURBT is both diagnostic (provides histology and staging) and therapeutic (removes non-muscle-invasive tumour completely).

  • Will I stay overnight?

    Most patients go home the same day once the catheter is removed and they have passed urine. An overnight stay is planned only for large resections, brisk bleeding or medical reasons — the team will tell you which to expect.

  • What happens if the biopsy shows cancer?

    Every new bladder cancer is discussed at a urology MDT. For non-muscle-invasive disease the next steps are usually a single dose of intravesical mitomycin, then risk-stratified surveillance or BCG. For muscle-invasive disease a staging CT and MDT decision on cystectomy or chemoradiotherapy follow.

  • When should I see a doctor urgently after the procedure?

    Fever, rigors, heavy bleeding, inability to pass urine, or severe abdominal pain — any of these after discharge is a same-day call to the ward or A&E, not something to wait on.

WhatsApp Call us

In practice, in London

Where cystoscopy rigid sits in a private London pathway

With cystoscopy rigid, the London question is usually about report turnaround and the radiologist reading it — not whether the scan is available. Public provision for cystoscopy rigid is competent but constrained by capacity. Private London clinics tend to have shorter diaries and longer appointment slots, so you get the same specialists with more time. For people who’ve been going round in circles with primary care, that first proper conversation is often what shifts things.

Once you’re in the private system for cystoscopy rigid, the pace picks up noticeably. Consultant slots run to time, imaging is usually available in the same building or a short walk away, and the report comes back typed and detailed. It’s the coordination that tends to feel different — one person on the other end of the phone, not a switchboard. For cystoscopy rigid specifically, the difference between a routine report and a sub-speciality read is where private care earns its keep.

We’re careful about what a private pathway for cystoscopy rigid can and can’t promise. It can compress a wait, put you in front of a subspecialist quickly, and get a proper report in your hands within a week. It can’t rewrite what the imaging or the bloods say. Setting that expectation up front tends to make the whole experience less stressful.

Pulse Healthcare concierge

Send us your enquiry

A concierge service for UK private healthcare. We match you with the best vetted clinics and consultants in our network - they then contact you directly.

So we can match you to the right clinician close to you.

Confidential. We respond within one working day.